|
|
|
Volumn 282, Issue 5391, 1998, Pages 1014-1015
|
|
A versatile cell line raises scientific hopes, legal questions.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOETHICS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BLASTOCYST;
CELL DIFFERENTIATION;
CELL LINE;
CELL TRANSPLANTATION;
CULTURE TECHNIQUE;
CYTOLOGY;
DRUG SCREENING;
EMBRYO RESEARCH;
FINANCIAL MANAGEMENT;
GENETICS AND REPRODUCTION;
GERON CORP.;
GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH CARE ORGANIZATION;
HUMAN;
NATIONAL INSTITUTES OF HEALTH;
NOTE;
PATENT;
RISK ASSESSMENT;
STEM CELL;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
GERON CORP.;
NATIONAL INSTITUTES OF HEALTH;
BIOETHICS;
BLASTOCYST;
CELL CULTURE TECHNIQUES;
CELL DIFFERENTIATION;
CELL LINE;
CELL TRANSPLANTATION;
DRUG EVALUATION, PRECLINICAL;
EMBRYO RESEARCH;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PATENTS;
RESEARCH SUPPORT;
RISK ASSESSMENT;
STEM CELLS;
UNITED STATES;
|
|
EID: 0032491621
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (28)
|
|
References (0)
|
